The transforming health economy is generating a fresh wave of challenges to pharmaceuticals and life sciences companies. Not all companies can live up to the expectations of this “patient first” economy in general, as many fail to understand the full scope of the compliance risk landscape. Successful firms are moving away from the traditional, top-down manufacturing and product promotion model toward a flexible, interactive approach that will give patients better tools and information about the drugs they take. All these efforts—on a holistic level—are underpinned by compliance standards.
As an enabling function, compliance at pharma companies covers multiple areas, including human resources, foreign corruption and bribery, patient assistance programs, communications with patients and health care professionals (HCPs), and reporting to regulatory bodies. The pharmaceutical industry is historically known for its adherence to stringent compliance rules to deal with
malpractices across the value chain. Any violation of regulatory methods or non-compliance of standards—from improper branding to masking safety information and disregarding quality manufacturing standards—could tarnish a company’s reputation, risking its future. Reputation problems will have a severe impact on revenue, loss of brand value and regulatory investigation.
In this edition, Pharma Tech Outlook Europe has shortlisted the best-of-breed vendors providing solutions and services in the realm of pharmaceutical compliance, also guiding organizations in this landscape to tackle today’s challenges and increase their revenue potential. With several innovative technological capabilities and success stories, the featured companies are continually proving their mettle. We hope this issue of the Pharma Tech Outlook helps you register growth and create better revenue streams.
We present “Top 10 Compliance Service Providers in Europe – 2021.”